Seeking Novel Therapeutics in Oncology and Neurology

A Canadian drug development and venture investment company with core focus on therapeutic technologies is seeking novel Canadian therapeutics in the fields of oncology and neurology. At minimum, a tool molecule showing therapeutic promise via modulation of an identified target is required as a developmental starting point. Therapeutics for other clinical indications will also be considered, provided the below criteria are met.

Approaches of Interest:

• Novel therapeutics available for partnering from Canadian biotech or academic organisations
• Diseases of...